Showing results (1801-1810 of 3,437) with videos related to
Sort By:
Pageof 344
The Journal of Pediatrics|August 17, 2022
Dual-Toxin ("Bivalent") Infant Botulism in California, 1976-2020: Epidemiologic, Clinical, and Laboratory AspectsMayuri V Panditrao, Connie H Chung, Jessica M Khouri, et al.Radiology|July 1, 2025
Current State of Fibrotic Interstitial Lung Disease ImagingLydia Chelala, Anupama G Brixey, Stephen B Hobbs, et al.Arxiv|June 9, 2023
An AI-Ready Multiplex Staining Dataset for Reproducible and Accurate Characterization of Tumor Immune MicroenvironmentParmida Ghahremani, Joseph Marino, Juan Hernandez-Prera, et al.Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|October 16, 2023
An AI-Ready Multiplex Staining Dataset for Reproducible and Accurate Characterization of Tumor Immune MicroenvironmentParmida Ghahremani, Joseph Marino, Juan Hernandez-Prera, et al.Biorxiv : the Preprint Server for Biology|May 13, 2026
Modeling Microbiome Modulation of Tumor Metabolic Networks to Predict Synergistic TherapiesAnnie J Badenoch, Zeyang Pang, Carolina H Chung, et al.Heart Rhythm|May 23, 2013
Lone atrial fibrillation is associated with pectus excavatumNicole T Tran, J Larry Klein, J Paul Mounsey, et al.The Journal of Biological Chemistry|August 8, 2006
ATR, PML, and CHK2 play a role in arsenic trioxide-induced apoptosisYeonsoo Joe, Jae-Hoon Jeong, Shutong Yang, et al.NPJ Primary Care Respiratory Medicine|January 9, 2015
Methodological quality of meta-analyses on treatments for chronic obstructive pulmonary disease: a cross-sectional study using the AMSTAR (Assessing the Methodological Quality of Systematic Reviews) toolRobin S T Ho, Xinyin Wu, Jinqiu Yuan, et al.Journal of Biomedical Optics|October 10, 2018
Intracellular oxygen mapping using a myoglobin-mCherry probe with fluorescence lifetime imagingRozhin Penjweini, Alessio Andreoni, Tilman Rosales, et al.Oral Oncology|March 6, 2022
Early response dynamics predict treatment failure in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with cetuximab and nivolumabDaniel J Glazar, Matthew Johnson, Joaquim Farinhas, et al.Pageof 344